{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:01:57Z","timestamp":1790665317381,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11060-021-03696-9","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T11:03:31Z","timestamp":1610708611000},"page":"279-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Evolution of the neurosurgical management of progestin\u2010associated meningiomas: a 23-year single\u2010center experience"],"prefix":"10.1007","volume":"152","author":[{"given":"Henri","family":"Malaize","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Samoyeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Zanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Benzakoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Zah-Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Edjlali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnault","family":"Tauziede-Espariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Dezamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Parraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Chr\u00e9tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Varlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Plu-Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Oppenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-9844","authenticated-orcid":false,"given":"Johan","family":"Pallud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"3696_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G et al (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015. Neuro-Oncol 20:iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro-Oncol"},{"key":"3696_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307\u2013314. https:\/\/doi.org\/10.1007\/s11060-010-0386-3","journal-title":"J Neurooncol"},{"key":"3696_CR3","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3205\/oc000027","volume":"5","author":"C Sys","year":"2015","unstructured":"Sys C, Kestelyn P (2015) Unilateral proptosis and blindness caused by meningioma in a patient treated with cyproterone acetate. GMS Ophthalmol Cases 5:2193\u20131496. https:\/\/doi.org\/10.3205\/oc000027","journal-title":"GMS Ophthalmol Cases"},{"key":"3696_CR4","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awy108","volume":"141","author":"NM Nota","year":"2018","unstructured":"Nota NM, Wiepjes CM, de Blok CJM et al (2018) The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment. Brain 141:2047\u20132054. https:\/\/doi.org\/10.1093\/brain\/awy108","journal-title":"Brain"},{"key":"3696_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.endonu.2012.07.004","volume":"60","author":"MT Bergoglio","year":"2013","unstructured":"Bergoglio MT, G\u00f3mez-Balaguer M, Almonacid Folch E et al (2013) Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual. Endocrinol Nutr 60:264\u2013267. https:\/\/doi.org\/10.1016\/j.endonu.2012.07.004","journal-title":"Endocrinol Nutr"},{"key":"3696_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1365-2125.2011.04031.x","volume":"72","author":"M Gil","year":"2011","unstructured":"Gil M, Oliva B, Timoner J et al (2011) Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study: risk of meningioma among users of high doses of cyproterone acetate. Br J Clin Pharmacol 72:965\u2013968. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.04031.x","journal-title":"Br J Clin Pharmacol"},{"key":"3696_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/09513590.2017.1395839","volume":"34","author":"I Mancini","year":"2018","unstructured":"Mancini I, Rotilio A, Coati I et al (2018) Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review. Gynecol Endocrinol 34:456\u2013459. https:\/\/doi.org\/10.1080\/09513590.2017.1395839","journal-title":"Gynecol Endocrinol"},{"key":"3696_CR8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.4140\/TCP.n.2016.500","volume":"31","author":"CP Alderman","year":"2016","unstructured":"Alderman CP (2016) Probable drug-related meningioma detected during the course of medication review services. Consult Pharm 31:500\u2013504. https:\/\/doi.org\/10.4140\/TCP.n.2016.500","journal-title":"Consult Pharm"},{"key":"3696_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.canep.2011.08.003","volume":"36","author":"L Cea-Soriano","year":"2012","unstructured":"Cea-Soriano L, Blenk T, Wallander M-A, Rodr\u00edguez LAG (2012) Hormonal therapies and meningioma: is there a link? Cancer Epidemiol 36:198\u2013205. https:\/\/doi.org\/10.1016\/j.canep.2011.08.003","journal-title":"Cancer Epidemiol"},{"key":"3696_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.annder.2018.04.001","volume":"145","author":"J-L Schmutz","year":"2018","unstructured":"Schmutz J-L (2018) Cyproterone acetate and meningioma: the latest findings. Ann Dermatol Venereol 145:390\u2013391. https:\/\/doi.org\/10.1016\/j.annder.2018.04.001","journal-title":"Ann Dermatol Venereol"},{"key":"3696_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/0022-4731(86)90320-1","volume":"25","author":"F Neumann","year":"1986","unstructured":"Neumann F, T\u00f6pert M (1986) Pharmacology of antiandrogens. J Steroid Biochem 25:885\u2013895. https:\/\/doi.org\/10.1016\/0022-4731(86)90320-1","journal-title":"J Steroid Biochem"},{"key":"3696_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.contraception.2008.10.017","volume":"79","author":"R Druckmann","year":"2009","unstructured":"Druckmann R (2009) Profile of the progesterone derivative chlormadinone acetate\u2014pharmocodynamic properties and therapeutic applications. Contraception 79:272\u2013281. https:\/\/doi.org\/10.1016\/j.contraception.2008.10.017","journal-title":"Contraception"},{"key":"3696_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.steroids.2011.02.002","volume":"76","author":"AO Mueck","year":"2011","unstructured":"Mueck AO, Sitruk-Ware R (2011) Nomegestrol acetate, a novel progestogen for oral contraception. Steroids 76:531\u2013539. https:\/\/doi.org\/10.1016\/j.steroids.2011.02.002","journal-title":"Steroids"},{"key":"3696_CR14","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMc071938","volume":"357","author":"R Gazzeri","year":"2007","unstructured":"Gazzeri R, Galarza M, Gazzeri G (2007) Growth of a meningioma in a transsexual patient after estrogen\u2013progestin therapy. N Engl J Med 357:2411\u20132412. https:\/\/doi.org\/10.1056\/NEJMc071938","journal-title":"N Engl J Med"},{"key":"3696_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2176\/nmc.48.227","volume":"48","author":"J Shimizu","year":"2008","unstructured":"Shimizu J, Matsumoto M, Yamazaki E, Yasue M (2008) Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration. Neurol Med Chir (Tokyo) 48:227\u2013230. https:\/\/doi.org\/10.2176\/nmc.48.227","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3696_CR16","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3174\/ajnr.A1978","volume":"31","author":"AMG Gon\u00e7alves","year":"2010","unstructured":"Gon\u00e7alves AMG, Page P, Domigo V et al (2010) Abrupt regression of a meningioma after discontinuation of cyproterone treatment: fig. 1. Am J Neuroradiol 31:1504\u20131505. https:\/\/doi.org\/10.3174\/ajnr.A1978","journal-title":"Am J Neuroradiol"},{"key":"3696_CR17","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/s00701-010-0787-2","volume":"152","author":"H Cebula","year":"2010","unstructured":"Cebula H, Pham TQ, Boyer P, Froelich S (2010) Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient. Acta Neurochir (Wien) 152:1955\u20131956. https:\/\/doi.org\/10.1007\/s00701-010-0787-2","journal-title":"Acta Neurochir (Wien)"},{"key":"3696_CR18","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00701-015-2532-3","volume":"157","author":"AL Bernat","year":"2015","unstructured":"Bernat AL, Oyama K, Hamdi S et al (2015) Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients. Acta Neurochir (Wien) 157:1741\u20131746. https:\/\/doi.org\/10.1007\/s00701-015-2532-3","journal-title":"Acta Neurochir (Wien)"},{"key":"3696_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4103\/jovr.jovr_21_17","volume":"13","author":"A Bernat","year":"2018","unstructured":"Bernat A, Bonnin S, Labidi M et al (2018) Regression of giant olfactory groove meningioma and complete visual acuity recovery after discontinuation of cyproterone acetate. J Ophthalmic Vis Res 13:355. https:\/\/doi.org\/10.4103\/jovr.jovr_21_17","journal-title":"J Ophthalmic Vis Res"},{"key":"3696_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.neuchi.2015.05.002","volume":"61","author":"C Botella","year":"2015","unstructured":"Botella C, Coll G, Lemaire J-J, Irthum B (2015) M\u00e9ningiomes intracr\u00e2niens et utilisation prolong\u00e9e d\u2019ac\u00e9tate de cyprot\u00e9rone \u00e0 dose conventionnelle chez la femme: \u00e0 propos de deux cas de r\u00e9gression tumorale apr\u00e8s arr\u00eat du traitement. Neurochirurgie 61:339\u2013342. https:\/\/doi.org\/10.1016\/j.neuchi.2015.05.002","journal-title":"Neurochirurgie"},{"key":"3696_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00701-019-03848-x","volume":"161","author":"T Passeri","year":"2019","unstructured":"Passeri T, Champagne P-O, Bernat A-L et al (2019) Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients. Acta Neurochir (Wien) 161:761\u2013765. https:\/\/doi.org\/10.1007\/s00701-019-03848-x","journal-title":"Acta Neurochir (Wien)"},{"key":"3696_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuchi.2019.12.013","author":"A Roux","year":"2020","unstructured":"Roux A, Tauziede-Espariat A, Zanello M et al (2020) Symptomatic progestin-induced atypical grade II meningioma. A first case report. Neurochirurgie. https:\/\/doi.org\/10.1016\/j.neuchi.2019.12.013","journal-title":"Neurochirurgie"},{"key":"3696_CR23","unstructured":"Ac\u00e9tate de cyprot\u00e9rone (Androcur et ses g\u00e9n\u00e9riques) et risque de m\u00e9ningiome: publication du rapport complet de l\u2019\u00e9tude de pharmaco-\u00e9pid\u00e9miologie\u2014Point d\u2019information\u2014ANSM : Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. https:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Acetate-de-cyproterone-Androcur-et-ses-generiques-et-risque-de-meningiome-publication-du-rapport-complet-de-l-etude-de-pharmaco-epidemiologie-Point-d-information. Accessed 10 May 2020"},{"key":"3696_CR24","unstructured":"Androcur et g\u00e9n\u00e9riques (ac\u00e9tate de cyprot\u00e9rone, 50 mg et 100 mg) et risque de m\u00e9ningiome: l\u2019ANSM publie des recommandations pour la prise en charge des patients\u2014Point d\u2019information\u2014ANSM : Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. https:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Androcur-et-generiques-acetate-de-cyproterone-50-mg-et-100-mg-et-risque-de-meningiome-l-ANSM-publie-des-recommandations-pour-la-prise-en-charge-des-patients-Point-d-information. Accessed 9 May 2020"},{"key":"3696_CR25","unstructured":"Lut\u00e9nyl\/Lut\u00e9ran et g\u00e9n\u00e9riques: recommandations pr\u00e9liminaires suite \u00e0 la confirmation du sur-risque de m\u00e9ningiome\u2014Point d\u2019Information\u2014ANSM : Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. https:\/\/www.ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Lutenyl-Luteran-et-generiques-recommandations-preliminaires-suite-a-la-confirmation-du-sur-risque-de-meningiome-Point-d-Information. Accessed 18 Nov 2020"},{"key":"3696_CR26","volume-title":"Pathology and genetics of tumours of the nervous system","author":"P Kleihues","year":"2000","unstructured":"Kleihues P, Cavenee WK, International Agency for Research on Cancer (2000) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon"},{"key":"3696_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl) 114:97\u2013109. https:\/\/doi.org\/10.1007\/s00401-007-0243-4","journal-title":"Acta Neuropathol (Berl)"},{"key":"3696_CR28","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl) 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol (Berl)"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03696-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-021-03696-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03696-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T14:34:46Z","timestamp":1616769286000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-021-03696-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3696"],"URL":"https:\/\/doi.org\/10.1007\/s11060-021-03696-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"19 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declares that they have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The requirement to obtain informed consent was waived for this observational retrospective study according to French legislation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All co-authors have seen and agree with the contents of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study received required authorizations (IRB #1: 2020\/08) of the institutional review board (IRB00011687). The requirement to obtain informed consent was waived for this observational retrospective study according to French legislation.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}